Sichenzia Ross Friedman Ference LLP Attorneys To Join Client DelMar Pharmaceuticals, Inc. at Nasdaq Opening Bell Ringing
Press Release – New York, NY – July 14, 2016 – Sichenzia Ross Friedman Ference LLP partners Gregory Sichenzia and David Manno and counsel Jeffrey Cahlon will join representatives of client DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a clinical stage drug development company with a focus on the treatment of cancer, at the Nasdaq MarketSite in Times Square to ring the July 14 opening bell.
Messrs. Sichenzia, Manno and Cahlon will take the stage along with a group of DelMar Pharmaceuticals leaders, including Chief Executive Officer Jeffrey Bacha. Join us and watch live on CNBC: 9:30am EST – Visit here to learn more about the NASDAQ Opening Bell
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $52 Million Underwritten Public Offering - November 15, 2018
- Sichenzia Ross Ference LLP Ranked by U.S. News for its “Best Lawyers List” for 2019 - November 13, 2018
- Sichenzia Ross Ference Represents Pareteum Corporation in Definitive Agreement to Acquire iPass, Inc. - November 13, 2018